Abstract
ObjectiveCardiovascular disease is the leading cause of morbidity and mortality in the USA. Thyroid analogs have emerged as a potential new therapeutic agent for cardiovascular disease. Thyroid hormones beneficially influence cardiac contractility and serum lipids but can also confer harmful effects
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have